In the Field - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Field

Pharmaceutical Technology


INTERACT in FEBRUARY...

"Worth reading

Protein Formulation and Delivery, Second Edition (Informa Healthcare, 2007)

Eds. Eugene J. McNally and Jayne E. Hastedt




The book summarizes recent research for formulators and drug-delivery specialists. Reviewed on http://pharmtech.com/.

"Worth attending

Interphex Puerto Rico

Venue: Feb. 14–Feb. 15, San Juan, PR

More Info: http://www.interphexpuertorico.com/

Biogenerics 2008: An Open Forum on Scientific and Regulatory Issues

Venue: Mar. 2–Mar. 4, Boston, MA

More Info: http://www.barnett.neu.edu/biogenerics/

WBF 2008 North American Conference: Shaping the Future of Manufacturing

Venue: Mar.24-Mar. 27, Philadelphia, PA

More Info: http://www.wbf.org/

Interphex 2008

Venue: Mar. 26-28, Philadelphia, PA

More Info: http://www.interphex.com/




See special pullout in this issue.

To recommend books, events, or websites, email


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here